Relay Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Relay Therapeutics

23/02/2024 03:04

* Relay Therapeutics Inc  RLAY.OQ  reported a quarterly
adjusted
loss of 67 cents​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -56 cents.  The mean expectation of twelve analysts for
the quarter was for a loss of 73 cents per share. Wall Street
expected results to range from -79 cents to -41 cents per share.
    * Reported revenue was zero​; analysts expected $127.27
thousand. 
    * Relay Therapeutics Inc's reported EPS for the quarter was
a loss
of 67 cents​.
    * The company reported a quarterly loss of $83.5 million.
    * Relay Therapeutics Inc shares had fallen by 4.8% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Relay
Therapeutics Inc is $24.00 
This summary was machine generated from LSEG data February 23 at
03:03 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.73          -0.67          Beat
 Sep. 30 2023      -0.83          -0.54          Beat
 Jun. 30 2023      -0.82          -0.81          Beat
 Mar. 31 2023      -0.69          -0.78          Missed